{"id":"W2601720937","doi":"10.1200/jco.2012.30.15_suppl.4118","title":"Updated results from a phase III trial of sunitinib versus placebo in patients with progressive, unresectable, well-differentiated pancreatic neuroendocrine tumor (NET).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; McGill University Health Centre","funders":"","keywords":"Medicine; Clinical endpoint; Sunitinib; Internal medicine; Placebo; Neuroendocrine tumors; Progression-free survival; Randomized controlled trial; Dosing; Gastroenterology; Overall survival; Urology; Oncology; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001268076,0.0003039133,0.002541505,0.0004144773,0.00003622003,0.00001258486,0.0003424828,0.00004035357,0.0003711462],"category_scores_gemma":[0.01390212,0.0002015176,0.0002861954,0.0005423399,0.0004172965,0.0003749688,0.0001373375,0.001800084,0.00001226734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001295203,"about_ca_system_score_gemma":0.001092493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001376886,"about_ca_topic_score_gemma":0.00007266398,"domain_scores_codex":[0.9920738,0.001671321,0.004016159,0.0003428523,0.001095382,0.000800452],"domain_scores_gemma":[0.9881917,0.006064185,0.003602911,0.000424136,0.0008404276,0.0008766526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9157684,0.01815257,0.05399849,0.00003117259,0.0004612684,0.005915204,0.0000295277,0.000009043341,0.0001022378,0.000005029561,0.002315067,0.003211979],"study_design_scores_gemma":[0.7998418,0.1095263,0.08231257,0.0002467449,0.0005396609,0.0002511538,0.00009827015,0.00005910942,0.0007978932,0.00001911575,0.006147533,0.0001599567],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947931,0.0001219488,0.000002461961,0.0007060129,0.001284162,0.001596454,0.00007989746,0.00001886388,0.00139714],"genre_scores_gemma":[0.9978515,0.00009605555,0.0007083839,0.0001716343,0.0008103765,0.00002124214,0.0001467624,0.00004374082,0.0001503275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1159267,"threshold_uncertainty_score":0.9944042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0853334689336662,"score_gpt":0.4497897587862639,"score_spread":0.3644562898525977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}